INJECTION SITE MUSCLE WEAKNESS

This adverse event was reported 48 times

INJECTION SITE MUSCLE WEAKNESS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 INCOBOTULINUMTOXINA 9 0.0015
1 FAMOTITINE 4 0.0014
2 INFLIXIMAB-DYYB 2 0.0006
3 LABETALOL 4 0.0003
4 SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 4 0.0002
5 ESZOPICLONE 4 0.0002
6 TEZEPELUMAB-EKKO 1 0.0001
7 ATOGEPANT 1 0.0001
8 ONABOTULINUMTOXINA 9 0.0001
9 OXYBUTYNIN CHLORIDE 1 0.0001
See all drugs enriched for association with INJECTION SITE MUSCLE WEAKNESS